product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-AMPKα (Thr172) (40H9) Rabbit mAb (Biotinylated)
catalog :
5256
clonality :
monoclonal
host :
rabbit
conjugate :
biotin
antigen modification :
phosphorylated
clone name :
40H9
reactivity :
human, mouse, rat
application :
western blot
more info or order :
citations: 13
Reference |
---|
Estañ M, Calviño E, Calvo S, Guillén GuÃo B, Boyano Adánez M, de Blas E, et al. Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activities. PLoS ONE. 2014;9:e115250 pubmed publisher
|
da Rocha J, Trapani L, Segatto M, La Rosa P, Nogueira C, Zeni G, et al. Molecular effects of diphenyl diselenide on cholesterol and glucose cell metabolism. Curr Med Chem. 2013;20:4426-34 pubmed
|
product information
SKU :
5256S
Product-Name :
Phospho-AMPKα (Thr172) (40H9) Rabbit mAb (Biotinylated)
Size :
100 ul
Price-(USD) :
291 USD
Species-x-Reactivity :
H, M, R, Hm, Mk, Dm, Sc
Applications :
Western blot
Product-Category :
Metabolism
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
62
Host :
Rabbit
Target :
AMPK-alpha1 (Thr183) phosphate/AMPK-alpha2 (Thr172) phosphate
more info or order :
company information
Cell Signaling Technology
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
review
product type
related products
browse more products
questions and comments